2023 annual financial data
Xenetic Biosciences 2023 Net margin
Direct answer
Net margin was -162.78%.
Operating income was -4,515,715 USD and net income was -4,134,578 USD.
Operating cash flow was -4,114,219 USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,539,986 USD
- Operating income
- -4,515,715 USD
- Net income
- -4,134,578 USD
- Operating cash flow
- -4,114,219 USD